Bionano Genomics (BNGO) Cash from Operations Growth (1y) (2018 - 2026)
Bionano Genomics (BNGO) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 186.74% |
| 10 | Bionano Genomics | 11.87 Mn | -1.82 Mn | 3.25 Mn | -106.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -106.22% |
| Dec 31, 2025 | 36.50% |
| Sep 30, 2025 | 55.53% |
| Jun 30, 2025 | 83.38% |
| Mar 31, 2025 | 90.17% |
| Dec 31, 2024 | 78.16% |
| Sep 30, 2024 | 49.38% |
| Jun 30, 2024 | 42.83% |
| Mar 31, 2024 | 13.21% |
| Dec 31, 2023 | 13.73% |
| Sep 30, 2023 | 10.79% |
| Jun 30, 2023 | -29.52% |
| Mar 31, 2023 | 0.25% |
| Dec 31, 2022 | -34.72% |
| Sep 30, 2022 | -47.50% |
| Jun 30, 2022 | -128.13% |
| Mar 31, 2022 | -133.70% |
| Dec 31, 2021 | -111.68% |
| Sep 30, 2021 | -82.32% |
| Jun 30, 2021 | -72.06% |